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An exploratory study of the views of pharmacy staff on the management of patients with 
undiagnosed skin problems  




The Department of Health strategy document “Pharmacy in England” highlights that 
community pharmacies are ideally placed for “routinely promoting self-care”. Sales of 
Skincare products in pharmacies account for nearly one-fifth of all over-the-counter 
transactions yet there is little research on pharmacy management of dermatological 
conditions, especially symptomatic skin problems. 
Objectives 
The aim of this study was to explore pharmacist and medicine counter assistant (MCA) 
perceptions of community pharmacy management of patients presenting with symptomatic 
skin problems. 
Methods 
Semi-structured telephone interviews with a ten pharmacists and15  MCAs from seven 
pharmacies in the north east of England. Interviews focused on perceptions of their role in 
managing symptomatic skin problems and views on why people sought pharmacy advice 
and any barriers to management. 
Results 
Pharmacists defined two key themes that defined their role; triage and reassurance. In 
contrast, MCAs defined their role as information gatherers and independent advisors. 
Themes identified by both pharmacists and MCAs relating to the use of pharmacy as a 
source of advice were convenience, the perceived non-serious nature of conditions and 
inaccessibility of the GP. Additionally, MCAs believed familiarity with the pharmacist was 
important. Both pharmacists and MCAs identified their lack of dermatological knowledge as 
a barrier with pharmacists reporting insufficient time to deal effectively with patients.  
Conclusion 
Our findings suggest that the role of pharmacists and MCAs is complementary; MCAs screen 
and provide the necessary information to pharmacists. Nevertheless, a major barrier to 
pharmacy supported self-care of symptomatic skin problems is a perceived lack of 
knowledge and training in dermatology. Further research to define pharmacy staff training 




A key advantage of community pharmacy is the high level of accessibility to healthcare 
advice without the need for formal appointments. Pharmacists are ideally placed to offer 
advice and treatment to patients seeking professional input in order to facilitate self-care.1 
In recent years, the United Kingdom (UK) Government has outlined its aspirations for 
pharmacists and their role in supporting self-care through white papers such as Pharmacy in 
England2 by committing to increasing the range of medicines over-the-counter (OTC) and 
more extensive minor ailment schemes that allow free access to certain treatments for 
patients who are normally exempt from prescription charges. While Government policy 
endeavors to promote the role of pharmacists, several studies demonstrate that pharmacy 
counter staff, who are the first point of contact for consumers entering a pharmacy, often 
provide advice independent of the pharmacist.3, 4  
One area where there is a potentially significant demand for support in primary care is 
dermatology, with a large number of people living with skin problems. Recent evidence 
suggests that skin problems are responsible for over 13 million general practitioner (GP) 
appointments every year in the UK, and are the most common reason for visiting GPs with a 
new problem.5 The role of pharmacists in managing skin problems is largely unknown but 
possibly vast given that community pharmacy retail sales data suggest that as much as 17% 
of all OTC sales in the UK are for skin care products6 which is equivalent to the volume of 
sales attributable to cough and cold remedies. Unfortunately, sales data are unable to 
distinguish between requests for specific products and symptom-related requests for 
advice. For example, patients may request treatment for an existing pre-diagnosed skin 
problem or alternatively seek advice on a symptomatic or undiagnosed condition. In both 
instances the outcome of the consultation might be the same (e.g. sale of a skin care 
product) but the latter case requires more input from pharmacy staff due to the need for an 
extended consultation involving questioning, assessment and possibly examining the 
patient. 
Some insight into the frequency with which patients with symptomatic skin conditions seek 
advice in pharmacies can be gleaned from observational studies. Although limited in study 
number and design, evidence from these studies reveal that symptomatic skin problems 
account for between 12 and 23% of all symptom-based requests for advice.7,8 Consequently 
symptomatic skin problems could potentially generate a considerable amount of work for 
pharmacists and their staff.  
In order to help direct and promote future initiatives that encourage pharmacy-assisted self-
care for patients with symptomatic skin problems, it is important to explore the perceptions 
of patients and pharmacy staff in an effort to understand advantages and disadvantages to 
managing such problems within community pharmacies. This study forms part of a wider 
investigation that also included interviews with patients who visited pharmacies for advice 
on symptomatic skin problems, the results of which have been published elsewhere.9 
 
Aim of the study 
This study aimed to explore the perceptions of pharmacy staff on their role in managing 
symptomatic skin problems in pharmacies and what they believed were the key facilitators 
and barriers to managing such problems within the community pharmacy setting. 
Methods 
This study involved semi-structured telephone interviews. Draft semi-structured interview 
guides were developed by discussion among the research team and based on the extant 
literature. The interviews involved a series of open questions designed to explore 
pharmacist and MCA perceptions of two key areas: their own role in managing symptomatic 
skin problems; and the advantages and disadvantages for patients seeking community 
pharmacy advice on these problems. The interview guides were piloted (one pharmacist and 
one MCA) and designed to last around 20 minutes. No major issues were identified during 
piloting except for some of the questions for the MCA interviews, which were subsequently 
modified to improve clarity. The topic guide used for pharmacists and MCAs is shown in the 
Box. 
 
Recruitment and Sampling 
Pharmacies were recruited through a contact at the South Humber Primary Care NHS Trust, 
whose role was to help develop research studies in community pharmacy and maintained  a 
register of pharmacies within the area that were willing to participate in research. The aim 
was to recruit sufficient pharmacies to provide 10 pharmacists and 15 MCAs. A letter was 
sent to all potentially interested pharmacies and seven agreed to participate. The selected 
pharmacies provided a suitable range of settings and included: three suburban; two rural; 
one healthcare centre and one supermarket. One of the pharmacies employed three 
pharmacists who worked on a shift rotation and all agreed to participate. The researcher 
contacted the MCAs explaining the nature of the study and gained informed, written 
consent. At one of the sites (supermarket), the two MCAs declined to participate and 
therefore additional MCAs were recruited from the healthcare centre pharmacy. We 
included only pharmacists who worked solely in community practice and MCAS who had 
worked in pharmacy for at least 12 months. We excluded pharmacist locums who worked 
only part-time in community pharmacy and MCAs who had been in employed in the 
pharmacy for less than 12 months. 
The local NHS research ethics committee advised that NHS ethical approval was not 
required for the study. Approval was obtained from the Ethical Review Panel of the School 
of Pharmacy and Life Sciences at Robert Gordon University. Written, informed consent was 
obtained from all participants.  
Data analysis 
Interviews were conducted at a mutually convenient time away from the pharmacy to avoid 
disruptions. The interviews were digitally recorded and transcribed verbatim. Analysis of the 
transcripts was carried out using the framework approach10 based on topics from the 
interview guide and data managed using N-Vivo (version 9.2, QSR International). The coding 
framework was developed independently by two members of the research team.  
Results 
The characteristics of the pharmacists are shown in Table 1 and the MCAs in Table 2. 
Pharmacists and MCAs were asked to consider how they perceived their roles when dealing 
with requests for advice from patients with symptomatic skin problems.  
Pharmacists 




Virtually all of the pharmacists felt their principal role to be one of triage; assessing the 
presenting problem and helping the patient decide if the skin condition was amenable to 
treatment with over-the-counter products or if it warranted referral to the GP as illustrated 
by one pharmacist.  
 
“Making a decision for the patient, whether it is something that they should really go 




In addition, several pharmacists conjectured that their role also involved the provision of 
reassurance to patients.  
“I think it’s really important that the patients get reassured… let’s take chicken pox as 
an example. Mom comes in with the little child whose got chicken pox and they’re 
terribly worried what’s going to happen and for the most part it’s managing the 
symptoms, you don’t need to see a doctor… so I feel our role really is reassurance…” 
[PH6] 
Medicine Counter Assistants 
The two key themes to emerge from MCAs’ perceptions of their role were: 
• Information gatherers 
• Independent advisors 
 
Information gatherers 
Many of the MCAs felt that their primary function was to establish the nature of the 
patients’ problem through questioning before handing over to the pharmacist if they were 
unsure about how to manage the problem. 
 “I’d have a look at it and like ask all the questions before then just referring to the 
pharmacist just to have another look at it. So I think I’d gather all the evidence really 
or gather all the information and then pass that on” [MCA 3] 
Independent advisors 
Nevertheless, some MCAs felt sufficiently confidence to help resolve the patients’ problem 
if possible without reference to the pharmacist. 
“the role would probably be trying to distinguish if I knew anything about it and 
trying to help the patient and not take up as much of the pharmacist’s time or if I 
don’t know anything, pass it on to the pharmacist who may know more” [MCA5]  
This independent advisory role was born out of experience acquired over the years, 
augmented, to some extent by familiarity with common skin problems such as chicken pox 
encountered with their own children.  
“…I think you just pick up more and more the more you work there and things you 
hear and things you see so …I mean I’ve had three children of my own so I am sort of 
quite good in recognising chicken pox …”  [MCA12] 
A second MCA discussed how working in pharmacy for several years had provided her with 
a good deal of experience, allowing her to act independently, referring to the pharmacist 
only where necessary.   
“I’ve been at the pharmacy for 16 years so I’ve got quite a broad knowledge of what 
it could be but if I’m not sure I will ask my pharmacist” [MCA13] 
 
Facilitators to managing undiagnosed skin problems in a pharmacy 
Key themes identified by pharmacists and MCAs are shown in Table 3 and illustrated with 
quotes for the key themes below. 
1. Convenience 
Most pharmacists commented that convenience and easy accessibility to healthcare advice 
were key factors influencing patients’ choice of pharmacy for advice. As one pharmacist 
explained, patients were able to obtain a professional opinion much faster. 
“… the common thing would be simplicity…. seeing the doctor is going to take a lot 
more time whereas they can walk in and... we’re able to give what they feel is a more 
qualified advice”  [PH10] 
This accessibility was seen as an important facilitator especially for mothers with young 
children as one MCA (a young mother herself) explained. 
 
“…if they’ve got children it’s easier to pop into the chemist rather than going to the 
doctors if they don’t have to…” [MCA1] 
2. Inaccessibility of the GP  
A second theme identified by staff and therefore a reason for seeking advice in the 
pharmacy, was the difficulty in accessing a GP. 
 “… Usually they can’t get in at the doctors, so more often than not they want 
something there and then rather than having to wait and see a GP”  [MCA15] 
This view was shared by pharmacists.  
“…quite a lot of people will say it’s difficult to get into [the] doctors. They have to 
make an appointment; they have to wait a few days and…that’s why they come to 
the pharmacy” [PH8] 
 
3. Perceived severity 
A number of pharmacists and MCAs speculated that the patients elected to visit a pharmacy 
rather than the GP because they viewed skin conditions as relatively minor in nature as 
outlined by one pharmacist.  
“…I think mainly it’s because they don’t usually think it’s something serious and they 
don’t really want to bother the GP … “[PH4] 
This view was echoed by MCAs. 
“I think some people think that its [skin problems] relatively minor and I don’t want 
to bother the doctor with it because they think that the doctor might think they’re 
wasting his time…”  [MCA8] 
 
4. Range of skincare products available 
Coupled with the supposed minor nature of skin problems, some MCAs remarked on how 
the wide range of treatments available from pharmacies, offered a portal for self-care as 
illustrated by one of them. 
“..People realise there’s more products you can buy and I also think that there’s more 
and more staff there [in pharmacies] that are trained than there’s ever been before 
... and people are realising… we can offer everything almost bar a prescription …so 
they come to us first…”” [MCA14] 
One pharmacist agreed, suggesting that convenience coupled with a wide range of skin care 
problems, provided patients with the opportunity to self-treat.  




Although pharmacists believed that triage was predominately their role, both groups 
recognised the importance of the initial pharmacy contact as a justification for going to see 
the GP if necessary. 
“…because we can often solve the problem, if we can’t we can give them the 
confidence to go to the doctor… ” [PH10]  
Moreover, initially seeking advice in the pharmacy meant that if staff were concerned about 
a patients’ skin condition, they would seek to convince them to visit the GP. 
“Some people don’t think they’re [skin problems] quite serious so they’ll come in and 
just say can I have this or that and we‘ve got to say I think you need to go to the 
doctors for that…”” [MCA1] 
 
6. Familiarity with the pharmacist 
MCAs mentioned how previously receiving positive advice from a particular pharmacist 
added value to that advice. Patients were therefore more inclined to use the same 
pharmacist in the future as one MCA explained. 
  “…A lot of people do trust [names the pharmacist]… and have got a very high 
opinion of our pharmacist and so they would come to see [them] as their first port of 
call” [MCA2] 
 
Perceived potential barriers to managing undiagnosed skin problems in a pharmacy 
Key themes identified as potential barriers associated with managing symptomatic skin 
problems in pharmacies are listed in Table 3. Illustrative quotes relevant to these key 
themes are given below. Only a few of the MCAs identified any specific barriers. 
1. Time constraints 
The lack of time due to high volume dispensing, was seen as a barrier as one pharmacist 
explained.  
“…in a busy pharmacy … it’s very difficult with pressure on your time to actually get 
out there and speak to patients … and it’s terrible but you’re thinking in the back of 
your mind if I spend another five minutes out here with this patient then when I get 
back there’s a huge queue …” [PH6] 
2. Lack of Knowledge 
Lack of knowledge and confidence in recognising skin conditions was another barrier 
mentioned by some of the pharmacists as described by one of them.  
“I’ve got limited knowledge when it comes to dermatology. I treat very low level… I 
tend to refer a good portion of patients that have anything that lasts longer than a 
few days to the GP” [PH2] 
In addition, one MCA felt that pharmacist’s lack of knowledge would result in a less 
thorough consultation than that provided by a GP.  
“…I mean you wouldn’t get it [skin problem] looked at quite as well as you would if 
you went to see the doctor, something could be missed I suppose, but if you were 
only looking for a quick diagnosis then that’s fair enough going to the chemist…but if 
you wanted something a bit more thorough then doctors [sic] is the place to go to I 
suppose” [MCA4] 
 
3. Potential for misdiagnosis 
Some of the MCAs ventured that due to the differences in training between pharmacists 
and GPs there was the possibility that pharmacists might not be able to recognise a 
particular skin condition or even misdiagnose the problem. 
“…obviously they’re [pharmacists] not a doctor … I would say things probably could 
be missed…” [MCA11] 
 
4. Treatment costs 
A further barrier suggested by pharmacists was the high cost of treatments. If the product 
recommended by the pharmacist could be obtained on prescription, patients would often 
then visit their GP rather than paying for it. 
 
“.. if product is actually expensive it’s also a barrier and [if] it’s on prescription they 
try and go to the doctor”  [PH7] 
 
 
5. Lack of effective products 
One of the pharmacists described the difficulties caused by a lack of effective treatments.  
“if I see someone with impetigo you can assess the severity of it …and you know 
they’re going to need fucidin or flucloxacillin …because they need to go and see a 
doctor for a prescription” [PH6] 
The inability to supply certain prescription only products was perceived as a hindrance to 
patient care as described by one MCA. 
 “Well there are certain items that are only available on prescription. So some items 




6. Location of the problem 
The site of a skin problem was a barrier especially if it was a patient of the opposite sex as 
one pharmacist explained. 
“..The site of the rash can be a problem …..so there’s sometimes a need for 
chaperoning and we haven’t got the space to really fit three people into the 
consulting room and comfortably be able to examine [some] one…” [PH3] 
Nonetheless, even with a consultation room, one MCA believed that some patients might be 
unwilling to reveal a skin problem if it was in a private area of their body. 
“Where the rash is probably located, they may not feel comfortable showing 
somebody it even if it was in a consultation room …” [MCA10] 
 
Discussion 
This is the first study to explore pharmacist and MCA perceptions on the pharmacy 
management of symptomatic skin problems. Pharmacists viewed themselves primarily as 
assessors or filters for the GP as noted in earlier studies.11-13 In contrast, MCAs perceived 
themselves as the first point of contact for patients and that their primary role was to 
undertake an initial assessment of the presenting problem, echoing the views MCAs in a 
recent study that explored their role in pharmacies.14 Some MCAs remarked on how they 
endeavoured to help patients wherever possible without input from the pharmacist and 
there is some evidence to substantiate this view.3, 15,16 
 
The results suggest there is possibly some scope for MCAs to act as independent advisors. 
The greater use of pharmacy staff has obvious advantages, especially in busy pharmacies, 
but requires further work to establish the dermatological knowledge base of MCAs. There 
appeared to be a consistency of themes derived from the interviews with both groups. 
Patients with symptomatic skin problems choose pharmacies for several reasons. Principle 
drivers included accessibility, lack of GP appointments, the potential for triage and the 
perceived minor nature of skin conditions. Equally important facilitators included personal 
factors such as familiarity with a pharmacist and the scope of self-care due to the wide 
range of dermatological products available and these findings are consistent with previous 
studies of consumer behaviour.17-19 Many of the MCAs assumed that given equality of 
access, patients would prefer to visit their GP and therefore pharmacies were used only out 
of necessity, a view noted in a recent qualitative study exploring the public’s opinions on the 
role of community pharmacists.20 Moreover, non-peer reviewed consumer research, has 
endorsed the view that the GP is the preferred source of health information by patients 
compared to community pharmacists.21 
 
Pharmacists themselves identified two key barriers namely, lack of time and inadequate 
knowledge about skin conditions. Lack of time for patient interaction has been cited as a 
problem by others22 as well as a barrier to implementing evidence-based practice.23 Some of 
the MCAs also recognised a lack of knowledge among pharmacists, as a potential barrier, 
highlighting the possibility for misdiagnosis.  
 
The results obtained in the present study to some extent mirror those obtained from our 
parallel study of patients presenting at pharmacies with symptomatic skin problems (see 
Table 3). Several patients gave credence to the view of convenience posited by pharmacy 
staff, while others corroborated the belief that their visit was out of necessity, being unable 
to access the GP.  Additionally, other patients noted that they felt their skin problem was 
non-serious and therefore more appropriate for a consultation at the pharmacy rather than 
with the GP. This use of pharmacies for minor ailments has also been shown to be a 
common theme in the international literature.24-26   
 
Familiarity and approachability of pharmacy staff as noted by MCAs was also a theme 
identified in the patient interviews. Patients appeared to be more comfortable consulting 
with a pharmacist, especially someone they knew and particularly in rural areas, echoing the 
views of patients in earlier studies.27,28 Though not mentioned by either pharmacists or 
MCAs, for some patients, the existence of a minor ailment scheme, especially one that 
included skin conditions, was an important facilitator, providing rapid access to advice and 
treatment obviating the need for the GP. 
 
Strengths and limitations 
Although this is the first qualitative study to explore pharmacy staff perspectives on the 
pharmacy management of symptomatic skin problems it does have some recognised 
limitations. However, one strength of the study is that due to the lack of research exploring 
the views of pharmacy staff on the management of skin problems, it adds to the limited 
body of knowledge in this area. Recognised limitations include the small sample size, the 
fact that the study was conducted in one geographic area and the inability to determine 
whether data saturation was achieved. The small sample size relative to quantitative 
studies, imposes a limitation in terms of the transferability of the study findings. 
Nevertheless, by their nature qualitative studies are not designed to be statistically 
generalizable to the wider population. A small sample size also raises the question of 
whether or not data saturation had been achieved. As the interviews with both pharmacists 
and MCAs progressed, no new themes emerged from later interviews hence it is possible 
that data saturation was achieved.  
An important role for pharmacists enshrined in much health policy has been to manage 
minor ailments and to keep such problems out of general practice. The belief that skin 
conditions are minor ailments has been re-enforced to some extent both by Government in 
white papers such as Pharmacy in England and national pharmacy organisations such as the 
National Pharmacy Association, who have considered skin conditions as minor ailments that 
can be managed through pharmacies.29 The inclusion of several skin problems in various 
local minor ailment schemes in parts of the UK, only serve to re-enforce this view and will 
undoubtedly result in patients choosing to visit pharmacists for advice on a skin problem.   
 
To facilitate an effective triage role, pharmacists and their staff require sufficient knowledge 
of different skin conditions or to at least be cognizant of the features that should prompt 
referral to the GP. Our study suggests that pharmacists observed an important gap in their 
dermatological knowledge which is a potential stumbling block to undertaking this role. Few 
studies have examined the ability of community pharmacists to recognise and manage 
different skin conditions though the evidence that is available, highlights the need for 
further training.30 Despite this potential lack of knowledge, support for pharmacists 
managing more skin problems was identified in a study of minor ailment management by 
GP.31  
With the belief that patients choose pharmacies because they are unable to see their GP, 
there is some scope for educating patients as to the position of pharmacists in the 
management of symptomatic skin problems and especially their potential triage role. In 
Breaking down the barriers – how community pharmacists and GPs can work together to 
improve patient care it is noted how “more effective promotion to the public … should be 
implemented, to encourage use of pharmacies for minor ailments and advice on self-care”.32 
In an effort to reduce unnecessary consultations for skin problems which are amenable to 
supported self-care, it is in the interest of GPs to promote and encourage patients to make 
greater use of pharmacies as a first port of call for advice on the management of their skin 
problem. However, an important first step is to explore the outcomes associated with 
pharmacist supported self-care for those with dermatological problems. Such data would 
provide an important platform upon which to encourage and develop future pharmacist 
roles for those with symptomatic skin problems. 
 
Conclusion 
This study suggests that in the management of symptomatic skin conditions the role of 
pharmacy staff is complementary. MCAs gather information on the skin problem and 
pharmacists assess its significance and suggest a course of action for the patient. Pharmacy 
staff agreed on the facilitators to using pharmacies and pharmacists identified lack of time 
and knowledge of dermatology as major barriers to helping patients. Given the potential 
time-constraints for pharmacists, it is conceivable that additional dermatology training, 
specifically targeted at MCAs would relieve the burden on pharmacists and allow them a 
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